Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015855
Filing Date
2021-11-15
Accepted
2021-11-15 07:01:30
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20210930x10q.htm   iXBRL 10-Q 1517248
2 EX-31.1 trvn-20210930xex31d1.htm EX-31.1 16922
3 EX-31.2 trvn-20210930xex31d2.htm EX-31.2 16052
4 EX-32.1 trvn-20210930xex32d1.htm EX-32.1 8921
5 EX-32.2 trvn-20210930xex32d2.htm EX-32.2 9265
  Complete submission text file 0001558370-21-015855.txt   6622609

Data Files

Seq Description Document Type Size
6 EX-101.SCH trvn-20210930.xsd EX-101.SCH 45484
7 EX-101.CAL trvn-20210930_cal.xml EX-101.CAL 54133
8 EX-101.DEF trvn-20210930_def.xml EX-101.DEF 175138
9 EX-101.LAB trvn-20210930_lab.xml EX-101.LAB 469660
10 EX-101.PRE trvn-20210930_pre.xml EX-101.PRE 328461
11 EXTRACTED XBRL INSTANCE DOCUMENT trvn-20210930x10q_htm.xml XML 1230215
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 211406243
SIC: 2834 Pharmaceutical Preparations